Finance

Lists
Why is SRTOY up 2,04%?
Dive Deeper
SRTOY:OTCMKTS
Sartorius Stedim Biotech S A Unsponsored France ADR
USD 24,49
+2,04%
(+0,49) 1D
6 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SRTOY...
Open
USD 25,12
High
USD 25,12
Low
USD 24,12
Mkt. cap
21,43 mjd
Avg. vol.
29,27 k
Volume
6,06 k
52-wk high
USD 26,54
52-wk low
USD 17,25
Beta
1,35
Shares outstanding
973,30 m
No. of employees
10 k
Open
USD 25,12
High
USD 25,12
Low
USD 24,12
Mkt. cap
21,43 mjd
Avg. vol.
29,27 k
Volume
6,06 k
52-wk high
USD 26,54
52-wk low
USD 17,25
Beta
1,35
Shares outstanding
973,30 m
No. of employees
10 k
News stories
From web sources and news partners
About Sartorius Stedim Biotech S A Unsponsored France ADR
CEO-
Employees10,5 k
Founded1978
Headquarters-
SectorHealth care
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
705,70 m
772,20 m
761,50 m
765,70 m
Cost of goods sold
378,30 m
455,30 m
416,10 m
406,90 m
Cost of revenue
378,30 m
455,30 m
416,10 m
406,90 m
Research and development expenses
30,10 m
31,70 m
38,40 m
35,30 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
157,60 m
171,60 m
163,40 m
163,30 m
Operating expense
192,70 m
183,80 m
196,10 m
204,80 m
Total operating expenses
571,00 m
639,10 m
612,20 m
611,70 m
Operating income
134,70 m
133,10 m
149,30 m
154,00 m
Other non operating income
-
-16,20 m
-100,00 k
-100,00 k
EBT including unusual items
87,40 m
77,70 m
119,10 m
126,60 m
EBT excluding unusual items
87,40 m
90,50 m
119,10 m
126,60 m
Income tax expense
22,70 m
30,50 m
31,00 m
32,90 m
Effective tax rate
25,97%
39,25%
26,03%
25,99%
Other operating expenses
5,00 m
-19,50 m
-5,70 m
6,20 m
Net income
64,20 m
47,30 m
88,10 m
93,00 m
Net profit margin
9,10%
6,13%
11,57%
12,15%
Earnings per share
0,94
1,12
1,17
1,25
Interest and investment income
4,10 m
7,60 m
16,40 m
6,90 m
Interest expense
-51,40 m
-24,50 m
-46,50 m
-34,20 m
Net interest expenses
-47,30 m
-16,90 m
-30,10 m
-27,30 m
Depreciation and amortization charges
-
-
-
-
EBITDA
213,60 m
138,90 m
230,40 m
233,40 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme